BioStem Technologies, Inc.
BSEM
$12.91
$3.6038.67%
| Weiss Ratings | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B | |||
| Rating Factors | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.46 | |||
| Price History | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 57.44% | |||
| 30-Day Total Return | 3.69% | |||
| 60-Day Total Return | -17.24% | |||
| 90-Day Total Return | -6.92% | |||
| Year to Date Total Return | -9.15% | |||
| 1-Year Total Return | -6.79% | |||
| 2-Year Total Return | 484.16% | |||
| 3-Year Total Return | 711.95% | |||
| 5-Year Total Return | 1,191.00% | |||
| 52-Week High % Change | -67.05% | |||
| 52-Week Low % Change | 37.52% | |||
| Price | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $28.26 | |||
| 52-Week Low Price | $6.77 | |||
| 52-Week Low Price (Date) | Jun 17, 2024 | |||
| 52-Week High Price (Date) | Nov 12, 2024 | |||
| Valuation | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 155.51M | |||
| Enterprise Value | 145.38M | |||
| Price/Earnings (TTM) | 16.13 | |||
| Earnings Per Share (TTM) | 0.58 | |||
| Earnings Per Share Growth | -164.39% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.93 | |||
| Price/Book (Q) | 6.66 | |||
| Enterprise Value/Revenue (TTM) | 0.69 | |||
| Price | $12.91 | |||
| Enterprise Value/EBITDA (TTM) | 6.98 | |||
| Enterprise Value/EBIT | 7.05 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 21.13M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 954 380 8342 | |||
| Address | 2836 Center Port Circle Pompano Beach, FL 33064 | |||
| Website | www.biostemtechnologies.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 9.79% | |||
| Profit Margin | 6.51% | |||
| Management Effectiveness | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 23.42% | |||
| Return on Equity | 141.92% | |||
| Income Statement | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 210.39M | |||
| Total Revenue (TTM) | 210.39M | |||
| Revenue Per Share | $9.96 | |||
| Gross Profit (TTM) | 199.54M | |||
| EBITDA (TTM) | 20.83M | |||
| EBIT (TTM) | 20.61M | |||
| Net Income (TTM) | 13.70M | |||
| Net Income Avl. to Common (TTM) | 13.70M | |||
| Total Revenue Growth (Q YOY) | 2,258.90% | |||
| Earnings Growth (Q YOY) | 543.40% | |||
| EPS Diluted (TTM) | 0.58 | |||
| EPS Diluted Growth (Q YOY) | 380.70% | |||
| Balance Sheet | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 14.61M | |||
| Cash Per Share (Q) | $0.69 | |||
| Total Current Assets (Q) | 101.38M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 22.83M | |||
| Current Ratio (Q) | 1.251 | |||
| Book Value Per Share (Q) | $1.40 | |||
| Total Assets (Q) | 104.20M | |||
| Total Current Liabilities (Q) | 81.01M | |||
| Total Debt (Q) | 4.48M | |||
| Total Liabilities (Q) | 81.37M | |||
| Total Common Equity (Q) | 22.83M | |||
| Cash Flow | BSEM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.55M | |||
| Cash from Financing (TTM) | 1.14M | |||
| Net Change in Cash (TTM) | 14.50M | |||
| Levered Free Cash Flow (TTM) | 9.82M | |||
| Cash from Operations (TTM) | 14.91M | |||
